SK

Sarala Kunjilekshmi

Active Director Director DIN 08683970
DIN 08683970 First appointment Jan 2020 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Sarala Kunjilekshmi

Data last updated:

Sarala Kunjilekshmi is a Director at Hybone Medical Private Limited (since 2020). The company operates in Electrnoics. Hybone Medical Private Limited reported revenue of ₹6.1 Lakh (FY 2025).

DIN 08683970
Primary Designation Director
Industry Electrnoics
First Appointment 30 Jan 2020
Oldest Company Age 6 yrs
Largest company Hybone Medical Private Limited · ₹6.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hybone Medical Private Limited U52601KL2020PTC061370
Director30 Jan 20202020₹6.1 Lakh (FY 2025)Active

Board colleagues of Sarala Kunjilekshmi

Directorship timeline

Open interactive timeline →
Hybone Medical Private Limited
Premium access

Shareholding and investment profile for Sarala Kunjilekshmi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarala Kunjilekshmi

Sarala Kunjilekshmi currently holds 1 directorship: Hybone Medical Private Limited (Director, since 30 Jan 2020, revenue ₹6.1 Lakh (FY 2025)).

Sarala Kunjilekshmi was first appointed on 30 Jan 2020 as Director at Hybone Medical Private Limited.

The current boards of Sarala Kunjilekshmi's companies include Raveendran Sarala Santhosh Kumar (Hybone Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available